Severe Fatigue and Memory Impairment Are Associated with Lower Serum Level of Anti-SARS-CoV-2 Antibodies in Patients with Post-COVID Symptoms.
Severe Fatigue and Memory Impairment Are Associated with Lower Serum Level of Anti-SARS-CoV-2 Antibodies in Patients with Post-COVID Symptoms.
复制标题
DOI:
10.3390/jcm10194337
复制
发表时间:
2021-09-23
影响因子:
3.9
通讯作者:
Csecsei P
中科院分区:
文献类型:
--
作者:
Molnar T;Varnai R;Schranz D;Zavori L;Peterfi Z;Sipos D;Tőkés-Füzesi M;Illes Z;Buki A;Csecsei P
Background: Post-COVID manifestation is defined as persistent symptoms or long-term complications beyond 4 weeks from disease onset. Fatigue and memory impairment are common post-COVID symptoms. We aimed to explore associations between the timeline and severity of post-COVID fatigue and anti-SARS-CoV-2 antibodies. Methods: Fatigue and memory impairment were assessed in a total of 101 post-COVID subjects using the Chalder fatigue scale (CFQ-11) and a visual analogue scale. Using the bimodal scoring system generated from CFQ-11, a score ≥4 was defined as severe fatigue. Serum anti-SARS-CoV-2 spike (anti-S-Ig) and nucleocapsid (anti-NC-Ig) antibodies were examined at two time points: 4–12 weeks after onset of symptoms, and beyond 12 weeks. Results: The serum level of anti-S-Ig was significantly higher in patients with non-severe fatigue compared to those with severe fatigue at 4–12 weeks (p = 0.006) and beyond 12 weeks (p = 0.016). The serum level of anti-NC-Ig remained high in patients with non-severe fatigue at both time points. In contrast, anti-NC-Ig decreased significantly in severe fatigue cases regardless of the elapsed time (4–12 weeks: p = 0.024; beyond 12 weeks: p = 0.005). The incidence of memory impairment was significantly correlated with lower anti-S-Ig levels (−0.359, p < 0.001). Conclusion: The systemic immune response reflected by antibodies to SARS-CoV-2 is strongly correlated with the severity of post-COVID fatigue.
登录
查看更多内容
影响因子:
7.4
作者:
Raijmakers RPH;Roerink ME;Jansen AFM;Keijmel SP;Gacesa R;Li Y;Joosten LAB;van der Meer JWM;Netea MG;Bleeker-Rovers CP;Xu CJ
通讯作者:
Xu CJ
DOI:
10.1016/j.jinf.2021.01.004
发表时间:
2021-03
期刊:
The Journal of infection
影响因子:
--
作者:
Moreno-Pérez O;Merino E;Leon-Ramirez JM;Andres M;Ramos JM;Arenas-Jiménez J;Asensio S;Sanchez R;Ruiz-Torregrosa P;Galan I;Scholz A;Amo A;González-delaAleja P;Boix V;Gil J;COVID19-ALC research group
通讯作者:
COVID19-ALC research group
影响因子:
9.3
作者:
Gardoni F;Boraso M;Zianni E;Corsini E;Galli CL;Cattabeni F;Marinovich M;Di Luca M;Viviani B
通讯作者:
Viviani B
影响因子:
6.4
作者:
Guthmiller JJ;Stovicek O;Wang J;Changrob S;Li L;Halfmann P;Zheng NY;Utset H;Stamper CT;Dugan HL;Miller WD;Huang M;Dai YN;Nelson CA;Hall PD;Jansen M;Shanmugarajah K;Donington JS;Krammer F;Fremont DH;Joachimiak A;Kawaoka Y;Tesic V;Madariaga ML;Wilson PC
通讯作者:
Wilson PC
影响因子:
8
作者:
McAndrews, Kathleen M.;Dowlatshahi, Dara P.;Kalluri, Raghu
通讯作者:
Kalluri, Raghu